Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bone pediatric

Chapman S, Hall CM (1997) Non-accidental injury or brittle bones. Pediatr Radiol 27 106-110 Crilly R (1972) Longitudinal overgrowth of the chicken radius. J Anat 112 11-18... [Pg.172]

Park, E.A. The imprinting of nutritional disturbances on the growing bone. Pediatrics 33 (Suppl.) 815-862 (1964)... [Pg.361]

Govoni, K., Baylink, D. J., and Mohan, S. 2005. The multi-functional role of insulin-hke growth factor binding proteins in bone. Pediatric Nephrology, 20, 261-268. [Pg.131]

Pediatric patients are also at higher risk for IBD-associated bone demineralization, which is accelerated by the use of systemic corticosteroids. [Pg.292]

Koo WWR, Succop PA, Bomschcin RL, et al. 1991. Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure. Pediatrics 87 680-687. [Pg.540]

Vatanparast H, Baxter-Jones A, Faulkner R, Baile D and Whiting S. 2005. Positive effects of vegetable and fruits consumption and calcium intake on bone mineral accrual in boys during growth from childhood to adolescence the University of Saskatchewan Pediatric Bone Mineral Accrual Study. Am J Clin Nutr 82 700-706. [Pg.50]

Teriparatide is contraindicated in patients at baseline increased risk for osteosarcoma (e.g., Paget s bone disease, unexplained alkaline phosphatase elevations, pediatric patients, young adults with open epiphyses, or patients with prior radiation therapy involving the skeleton). [Pg.42]

Phenothiazines Suspected or established subcortical brain damage (fluphenazine) blood dyscrasias (perphenazine, trifluoperazine, fluphenazine) bone marrow depression (perphenazine, trifluoperazine, fluphenazine) preexisting liver damage (perphenazine, trifluoperazine, fluphenazine) pediatric surgery (prochlorperazine) hypertensive or hypotensive heart disease of extreme degree (thioridazine). [Pg.1100]

Children The use of isotretinoin in pediatric patients less than 12 years of age has not been studied. Carefully consider isotretinoin use in pediatric patients 12 to 17 years of age, especially for those patients in whom a known metabolic or structural bone disease exists. [Pg.2038]

Vidal, K., van den, B. P., Lorget, F., and Donnet-Hughes, A. (2004b). Osteoprotegerin in human milk A potential role in the regulation of bone metabolism and immune development. Pediatr. Res. 55,1001-1008. [Pg.79]

Greer, F. R., Krebs, N. F., and Committee on, N. (2006). Optimizing bone health and calcium intakes of infants, children, and adolescents. Pediatrics 117, 578-585. [Pg.334]

Specker, B. L., Beck, A., Kalkwarf, H., and Ho, M. (1997). Randomized trial of varying mineral intake on total body bone mineral accretion during the first year of life. Available from http //pediatrics.aappublications.Org/cgi/content/abstract/99/6/el2 [Accessed July 2007]. [Pg.343]

Stuber, M.L., Nader, K., Yasuda, P., Pynoos, R.S., and Cohen, S. (1991) Stress responses after pediatric bone marrow transplantation. / Am Acad Child Adolesc Psychiatry 30 952—957. [Pg.415]

Friedman, A.G., Mulhern, R.K., Fairclough, D., et al. (1991) Midazolam premedication for pediatric bone marrow aspiration and lumbar puncture. Med Pediatr Oncol 19 499-504. [Pg.640]

Treatment of primary immunodeficiency states in which severe impairment of antibody forming capacity idiopathic thrombocytopenic purpura (IPT) bone marrow transplantation pediatric HIV infection... [Pg.473]

Salusky IB Are new vitamin D analogues in renal bone disease superior to calcitriol Pediatr Nephrol 2005 20 393. [PMID 15690188]... [Pg.978]

Bone marrow transplantation for sickle cell anemia Progress and prospects Iannone, R., Ohene-Frempong, K., Fuchs, E.J., Casella, J.F., Chen, A.R. (2005). Pediatr Blood Cancer, 44 (5) 436-440. [Pg.74]

Unal O, Berberoglu M, Evliyaoglu O, Adiyaman P, Aycan Z, Ocal G. Effects of bone mineral density of gonadotropin releasing hormone analogs used in the treatment of central precocious puberty. J Pediatr Endocrinol Metab 2003 16 407-11. [Pg.493]

The antibiotics that bind to DNA are nonspecific to the cell-cycle phase. Dactinomycin (actinomycin D and Cosmegen) binds to double-stranded DNA and prevents RNA synthesis by inhibiting DNA-dependent RNA polymerase. It is administered intravenously in the treatment of pediatric solid tumors such as Wilms tumor and rhabdomyosarcoma and for gestational choriocarcinoma. Dactinomycin causes skin reactions, gastrointestinal injury, and delayed bone marrow depression. [Pg.116]

UK L.G Strauss. T.M.Trischmanin,5.D.Rowley,J.M. Wlley.andC.I.Civin.Selection of normal human hematopoietic seem cells for bone marrow (ransplanlatlon using immunomagnctic microsplieres and CD34 antibody. Aai. / Pediatr. HematoL OncoL 13 217 (1991). [Pg.129]

Recently, lamivudine [LAM ih vue deen] or (-)-2 -deoxy-3 -thiacyti-dine (3TC) has been approved for treatment of HIV in combination with zidovudine. This dideoxynucleoside terminates the synthesis of the proviral DNA chain and also inhibits reverse-transcriptase of both HIV and hepatitis B virus (HBV). However, it does not affect mitochondrial DNA synthesis or bone marrow precursor cells. Resistance to zidovudine develops more slowly with the combination. Lamivudine has good bioavailability on oral administration and depends on the kidney for excretion. Though generally well tolerated, pancreatitis develops in a significant number of pediatric... [Pg.381]


See other pages where Bone pediatric is mentioned: [Pg.237]    [Pg.237]    [Pg.314]    [Pg.576]    [Pg.1108]    [Pg.1111]    [Pg.1406]    [Pg.534]    [Pg.472]    [Pg.529]    [Pg.399]    [Pg.265]    [Pg.272]    [Pg.339]    [Pg.310]    [Pg.635]    [Pg.828]    [Pg.59]    [Pg.144]    [Pg.215]    [Pg.156]    [Pg.281]    [Pg.283]    [Pg.277]    [Pg.471]    [Pg.170]   
See also in sourсe #XX -- [ Pg.524 ]




SEARCH



Pediatrics

© 2024 chempedia.info